PTRF Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP7421a
Background:
Termination of transcription by RNA polymerase I involves pausing of transcription by TTF1, and the dissociation of the transcription complex, releasing pre-rRNA and RNA polymerase I from the template. PTRF is required for dissociation of the ternary transcription complex.
Other Names:
Polymerase I and transcript release factor, Cavin-1, PTRF {ECO:0000312|EMBL:AAH661231}
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7421a was selected from the N-term region of human PTRF. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CAVIN1 (HGNC:9688)
Gene ID: 284119
Primary Accession: Q6NZI2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Termination of transcription by RNA polymerase I involves pausing of transcription by TTF1, and the dissociation of the transcription complex, releasing pre-rRNA and RNA polymerase I from the template. PTRF is required for dissociation of the ternary transcription complex.
Other Names:
Polymerase I and transcript release factor, Cavin-1, PTRF {ECO:0000312|EMBL:AAH661231}
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7421a was selected from the N-term region of human PTRF. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CAVIN1 (HGNC:9688)
Gene ID: 284119
Primary Accession: Q6NZI2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review